Clinical trial
Naltrexone in the Treatment of Pyromania
NCT00467454 · University of Minnesota, Other · Withdrawn
Key facts
| NCT number | NCT00467454 |
|---|---|
| Title | Naltrexone in the Treatment of Pyromania |
| Official title | A Double-Blind, Placebo-Controlled Study of Naltrexone in Pyromania |
| Lead sponsor | University of Minnesota, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pyromania |
| Intervention type | Drug |
| Interventions | Naltrexone, Placebo |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Apr 30, 2007 |
| Last update posted | Dec 14, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: